Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 12;59(1):14.
doi: 10.1007/s44313-024-00014-w.

Transfusion-transmitted infections

Han Joo Kim  1 , Dae-Hyun Ko  2
Affiliations
Review

Transfusion-transmitted infections

Han Joo Kim et al. Blood Res. .

Abstract

The risk of transfusion-transmitted infection (TTI) has always existed because transfused blood products are biological materials derived from humans. To prevent TTIs, screening strategies have been developed for various infectious diseases, such as hepatitis B virus, hepatitis C virus, and human immunodeficiency virus, contributing significantly to reducing TTI globally. Nevertheless, septic transfusion reactions (STRs) due to bacterial contamination remain an unresolved issue. Various infectious diseases can be transmitted through blood products, and preventive and selective screening strategies have been applied across different regions. Although multiple strategies, including culture-based and rapid detection kit-based methods, have been introduced to overcome STRs, complete prevention has not yet been achieved. Recently, pathogen inactivation methods have been developed to eliminate non-specific organisms rather than screening specific organisms. This approach is anticipated to contribute significantly to diminishing the risk of TTIs in the future.

Keywords: Hepatitis B virus; Hepatitis C virus; Human immunodeficiency virus; Pathogen inactivation; Transfusion-transmitted infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Science. 1983;220:868–871. doi: 10.1126/science.6189183. - DOI - PubMed
    1. CfD C. Pneumocystis carinii pneumonia among persons with hemophilia A. MMWR Morb Mortal Wkly Rep. 1982;31:365–367. - PubMed
    1. Gjerset GF, McGrady G, Counts RB, Martin PJ, Jason J, Kennedy S, et al. Lymphadenopathy-associated virus antibodies and T cells in hemophiliacs treated with cryoprecipitate or concentrate. Blood. 1985;66:718–720. doi: 10.1182/blood.V66.3.718.718. - DOI - PubMed
    1. Cohn C, Delaney M, Johnson ST, Katz LM, Schwartz J. Technical Manual. 21st. Bethesda: AABB; 2023.
    1. Kang JW, Shin S, Seo DH, Kang J, Ko DH, Song CE, et al. Estimation of the residual risk of transfusion-transmissible infectious agents in Korea. Korean J Blood Transfus. 2019;30:156–162. doi: 10.17945/kjbt.2019.30.2.156. - DOI

LinkOut - more resources